chitosan has been researched along with lovastatin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YP; Chen, CT; Chung, JG; Hsieh, SL; Huang, YS; Lii, CK; Lin, SY; Wu, CC; Yu, CC | 1 |
| Chen, HJ; Chen, YW; Hsieh, WL; Lai, CH; Lee, BS; Lee, CC; Wang, YP | 1 |
| Chen, YW; Hsieh, WL; Lai, CH; Lee, BS; Lee, CC; Lin, HP; Shih, WA; Takeuchi, Y | 1 |
| Dang, M; Huang, G; Huang, Z; Zhang, B; Zhang, W; Zhu, P | 1 |
| Dai Tran, L; Duc Le, G; Duc Mai, H; Long Bach, G; Ramadass, K; Sathish, CI; Thai, H; Thi Thach, L; Thi Thu Nguyen, T; Thi Tran, M; Thuy Nguyen, C; Van Can, M; Van Le, Q | 1 |
| Anton, N; Batool, F; Benkirane-Jessel, N; Huck, O; Klymchenko, A; Petit, C; Stutz, C; Vandamme, T | 1 |
| Chinh, NT; Dung, HT; Giang, BL; Hoang, T; Sathish, CI; Thang, DX; Vinu, A | 1 |
7 other study(ies) available for chitosan and lovastatin
| Article | Year |
|---|---|
Differential blood lipid-lowering effects of alkylsulfonated chitosan of different molecular weights in Syrian hamsters in vivo.
Topics: Alkylation; Animals; Anticholesteremic Agents; Chitosan; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Cricetinae; Diet, High-Fat; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Intestines; Liver; Lovastatin; Mesocricetus; Molecular Weight; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Sulfonic Acids; Triglycerides | 2012 |
Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs.
Topics: Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Bacteria; Bone Regeneration; Chitosan; Delayed-Action Preparations; Dogs; Drug Carriers; Lactic Acid; Lovastatin; Male; Microscopy, Electron, Transmission; Nanoparticles; Osteoblasts; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tetracycline | 2016 |
A functional chitosan membrane with grafted epigallocatechin-3-gallate and lovastatin enhances periodontal tissue regeneration in dogs.
Topics: Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Catechin; Cell Adhesion; Cell Proliferation; Chitosan; Delayed-Action Preparations; Dogs; Drug Carriers; Drug Liberation; Fibroblasts; Gingiva; Guided Tissue Regeneration; Humans; Lovastatin; Male; Membranes, Artificial; Tensile Strength | 2016 |
Assessment of fracture healing properties of lovastatin loaded nanoparticles: preclinical study in rat model.
Topics: Animals; Bone Density; Chitosan; Female; Fracture Healing; Lovastatin; Nanoparticles; Rats; Rats, Wistar | 2019 |
Characterization of chitosan/alginate/lovastatin nanoparticles and investigation of their toxic effects in vitro and in vivo.
Topics: Alginates; Animals; Calorimetry, Differential Scanning; Chitosan; Crystallization; Drug Carriers; Drug Liberation; Hydrogen-Ion Concentration; In Vitro Techniques; Lovastatin; Mice; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared; Toxicity Tests | 2020 |
Development of a thermosensitive statin loaded chitosan-based hydrogel promoting bone healing.
Topics: Animals; Atorvastatin; Bone Regeneration; Cells, Cultured; Chitosan; Epithelial Cells; Fibroblasts; Gingiva; Humans; Hydrogels; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Mice; Mice, Inbred C57BL; Porphyromonas gingivalis | 2020 |
Characterization and Drug Release Control Ability of Chitosan/Lovastatin Particles Coated by Alginate.
Topics: Alginates; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Hexuronic Acids; Lovastatin; Particle Size | 2020 |